Navigation Links
deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
Date:11/4/2008

REYKJAVIK, Iceland, November 4 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq:DCGN) today announced today that it has requested a hearing before a Nasdaq Listing Qualifications Panel to present a plan for regaining compliance with Nasdaq Marketplace Rule 4450(b)(1)(A), which requires a minimum market value of listed securities of $50 million. On October 31, 2008, deCODE received a Staff Determination Letter from The Nasdaq Stock Market LLC indicating that the Company had not regained compliance with this rule during the time period provided by Nasdaq in a previous notice as disclosed in the Company's press release dated October 6, 2008, and therefore its Common Stock is subject to delisting from The Nasdaq Global Market at the opening of business on November 11. Following the hearing request, the Company's common stock will continue to be listed on The Nasdaq Global Market pending the conclusion of the hearing process and during any extension period which may be granted by the Panel. It is expected that the hearing would be held within 45 days. The Panel has discretion to grant an extension not to exceed 180 days from the date of the Staff notification for the Company to regain compliance with applicable listing standards. There can be no assurance that the Panel will grant the Company's request for continued listing.

Alternatively, the Company may apply to transfer its securities to The Nasdaq Capital Market if it satisfies the continued inclusion requirements for that market, which include a minimum aggregate market value of listed securities of $35 million.

As of October 31, 2008, the Company had 61,848,584 shares of common stock outstanding, which would result in a market value of listed securities of $26.6 million ba
'/>"/>

SOURCE deCODE genetics Inc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
2. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
3. deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
4. Researchers decode viral process that prepares cells for HIV infection
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
6. deCODE genetics Announces Second Quarter 2008 Financial Results
7. deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
8. deCODE genetics to Webcast Presentations at Annual R&D Event
9. deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
10. deCODE genetics Announces First Quarter 2008 Financial Results
11. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Vital Imaging ™ has ... California, San Diego for a joint study which aims ... (Magnetic Resonance Imaging) with that of a supine Dynawell ... pursuit of improved healthcare by combining cutting edge technology ... extremely valuable tool for evaluating pathological changes in the ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/21/2013)... May 21, 2013 The Formulate Fusion ... solution for sales and marketing teams looking for a fully-functional ... the kit as “everything you’ll need to put together a ... Kit comes with a number of displays and accessories that ... 20 feet by 20 feet in size. These components vary ...
(Date:5/20/2013)... May 20, 2013 , ... Research Service (ARS) in treatment of mastitis ... , Trials to begin in the second half ... technology company Phosphagenics Limited (ASX: POH, OTCQX: ... (USDA) Agricultural Research Service (ARS) to develop and trial ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... Elekta, a global leader in radiation,oncology and ... at the 49th Annual Meeting of The American ... reduce,treatment times and increase efficiency. The meeting will ... Los Angeles Convention Center (Los Angeles,California, USA). Elekta ...
... N.J., Oct. 18 NPS,Pharmaceuticals, Inc. (Nasdaq: NPSP ... cash tender offer for any and all of its ... at midnight, New,York City time, on October 17, 2007. ... offer, $171.2 million principal,amount of the notes, representing approximately ...
... Glycominds Ltd., a,biodiagnostics company specializing in glycan biomarkers ... cancer, announced today the,appointment of Dr. Chen Even ... Chen, a board member since 2004, contributes more ... "We are very pleased to elevate Dr. Even ...
Cached Biology Technology:Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 2Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 3Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 4NPS Pharmaceuticals Announces Results of Tender Offer 2NPS Pharmaceuticals Announces Results of Tender Offer 3Glycominds Appoints Board of Directors Chairman 2Glycominds Appoints Board of Directors Chairman 3
(Date:5/21/2013)... Chicago College of Medicine will study gender differences in how ... source -- and how changes in fat metabolism play a ... grant from the National Heart, Lung and Blood Institute. , ... energy. These changes may play a major role in the ... women, says E. Douglas Lewandowski, director of the UIC Center ...
(Date:5/21/2013)... Where? Copenhagen, Denmark: Bella Center Congress Centre ... , Why? An annual meeting focusing ... manufacturing and installation, drawing on leading experiences from all ... from a record of more than 900 abstracts received ... and oral presentations, more than 460 visual presentation, 55 ...
(Date:5/20/2013)... the antibiotic colistin are also commonly resistant to ... to a study in mBio , the ... Microbiology. Cross-resistance to colistin and host antimicrobials LL-37 ... bacterial attack, could mean that patients with life-threatening ... crippled immune response. Colistin is a last-line drug ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... A new study from The Montreal Neurological Institute and Hospital ... to discover a molecular link between Parkinson,s disease and defects ... published in the prestigious journal Molecular Cell and ... , provides new insight into the mechanisms underlying Parkinson,s disease, ...
... the molecular process that can shut down a marauding, ... who suffer battlefield casualties, heart attacks, strokes, automobile accidents ... the January edition of Molecular Immunology. , The ... of a reaction first observed in the lab by ...
... Diseases (NIAID), part of the National Institutes of Health ... Tulane University for its ongoing efforts to treat and ... threatens hundreds of thousands of people annually in West ... The contract will include collaboration between Tulane; Scripps ...
Cached Biology News:Communication breakdown: what happens to nerve cells in Parkinson's disease 2Communication breakdown: what happens to nerve cells in Parkinson's disease 3Research could lead to way to halt deadly immune response 2Research could lead to way to halt deadly immune response 3Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever 2
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... A full-featured high-performance ICP-MS system designed ... sampling interface, Omega II off-axis ion lens, ... the 7500a can handle the widest range ... 2003, the 7500a now includes as standard ...
... the DH-2000, except that it uses a deep-UV ... range and comes with a shutter (controlled via ... Hz) The DH-2000 Deuterium Tungsten Halogen ... and tungsten halogen light sources in a single ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
Biology Products: